Monte Rosa Therapeutics shares owned by Barclays
Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in Monte Rosa Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Monte Rosa Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Monte Rosa Therapeutics by Barclays
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $541k | 73k | 7.41 |
| 2025-06-30 | $386k | 86k | 4.50 |
| 2025-03-31 | $214k | 46k | 4.63 |
| 2024-12-31 | $491k | 71k | 6.94 |
| 2024-09-30 | $289k | 55k | 5.31 |
| 2024-06-30 | $41k | 11k | 3.75 |
| 2024-03-31 | $154k | 22k | 7.06 |
| 2023-12-31 | $346k | 61k | 5.64 |
| 2023-09-30 | $63k | 13k | 4.78 |
| 2023-06-30 | $94k | 14k | 6.90 |
| 2023-03-31 | $118k | 15k | 7.81 |
| 2022-12-31 | $61k | 8.0k | 7.64 |
| 2022-09-30 | $10k | 1.2k | 8.22 |
| 2022-06-30 | $14k | 1.4k | 9.72 |
| 2022-03-31 | $128k | 9.1k | 14.05 |